Alzheimer’s Drug LMTX Falters in Final Stage of Trials
LMTX, which was developed by TauRx Therapeutics, did not appear to help patients over all, researchers said. A new type of drug to treat Alzheimer’s disease failed in its first big clinical trial, though there was a hint it might…